Background COVID-19 co-infections have been described with different pathogens, including filamentous and yeast fungi. Methodology A retrospective case series study conducted from February to December 2020, at a Brazilian university hospital. Data were collected from two hospital surveillance systems: ...
especially for patients with underlying diseases and who received immunosuppressive therapy. Among the opportunistic infections, fungal infections account for the most case reports in COVID-19 patients. Other reported pathogens were related to viral, bacterial, protozoa, and helminth infections...
Based on this evidence, we posit that therapies that boost NAD+ concentrations might play a role in preventing and treating severe COVID-19 and other viral infections. First described as a yeast fermentation factor over a century ago, today, NAD+ has risen to prominence as a regulator of ...
The COVID-19 pandemic is a sudden, difficult-to-control, and severe disease that can also appear to patients in dermatology. However, understanding disease and experience with it is still insufficient. Therefore, we would like to review patients with fungal infections in the COVID-19 pandemic ...
Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age. Epidemiol Infect. 1989;103(2):387–94. Article CAS PubMed PubMed Central Google Scholar Zeeshan M, Jabeen K, Ali AN, Ali AW, Farooqui SZ, Mehraj V, et al. Evaluation of immune response...
Aspergillosis and Candidiasis Athlete’s foot Ringworm and Yeast infections Skin Fungal Infections Fungal Diseases in Soil Anti-Fungal therapies Tags Infection Prevention & Control Conferences AsiaInfection Conferences 2022 AsiaInfection Control ConferencesHepatitis ConferencesParasitology ConferencesHealthcare Conferen...
The current frequency of COVID-19 in a pandemic era ensures that co-infections with a variety of co-pathogens will occur. Generally, there is a low rate of
The unrecognized threat of secondary bacterial infections with COVID-19. mBio 11, e01806–20 (2020). Article CAS PubMed PubMed Central Google Scholar Wang, A. et al. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc. Natl...
(M), and nucleocapsid (N), encoded by one-third of the CoV genomic RNA. The role of the spike glycoprotein (S) is particularly relevant as the determinant of species specificity in CoV infections (Kuo et al.2000), and has been explored as the major anti-CoV target (Trigueiro-Louro et...
permeability, systemic shock and multi-organ failure41,51. Many patients with severe COVID-19 also develop bacterial pneumonia, a secondary bacterial infection of the lungs52. These bacterial infections bolster pro-inflammatory responses that perpetuate cytokine storm, systemic inflammation and ARDS ...